Table 2a.
Kinetic parameters of arginine in human plasma after 1 week of oral supplementation with either citrulline or arginine‡
| Compound | Dose (mg) | Cmax (µmol l−1) | Tmax (h) | Cmin (µmol l−1) | AUC (µmol h l−1) |
|---|---|---|---|---|---|
| Citrulline | 750 bid | 54 ± 5 | 2.3 ± 0.7 | 19 ± 4 | 271 ± 38 |
| Citrulline | 1500 bid | 79 ± 8* | 1.6 ± 0.3 | 21 ± 4 | 421 ± 65* |
| Citrulline | 3000 bid | 149 ± 42*† | 1.4 ± 0.1 | 45 ± 5*† | 898 ± 67*† |
| Arginine SR | 1600 bid | 49 ± 6 | 3.7 ± 1.3§ | 19 ± 4 | 289 ± 50 |
| Arginine lR | 1000 tid | 84 ± 9 | 0.7 ± 0.1 | 10 ± 3 | 283 ± 51 |
P < 0.01 vs. arginine sustained-release (SR).
P < 0.01 vs. arginine immediate-release (IR).
P = 0.03 vs. arginine IR.
Kinetic parameters are calculated for baseline-placebo corrected data. Data are given as mean ± SEM. bid, twice daily.